Table 4.
Gastro-intestinal complaint | Day of FMTa | 1-week post-FMTa | 3-weeks post-FMTa | LTFUb |
---|---|---|---|---|
Nausea (% yes) | 20% (19/94) | 14% (13/96) | 11% (11/97) | 18% (13/73) |
Abdominal pain (% yes) | 33% (31/93) | 28% (27/97) | 21% (21/98) | 21% (15/71) |
Diarrhoea (% yes) | 52% (48/93) | 30% (29/97) | 27% (26/97) | 33% (24/73) |
Self-rated defaecation pattern (post-FMT vs before CDI episode) | n/a | n/a | ||
• Improved | 16% (13/80) | 38% (25/65) | ||
• Similar | 68% (54/80) | 46% (30/65) | ||
• Deteriorated | 16% (13/80) | 15% (10/65) |
LTFU: long-term follow-up; rCDI: recurrent Clostridioides difficile infection.
aA questionnaire is filled in by the patient or treating physician at regular follow-up 3–4 weeks post-FMT.
bLTFU: median 42 weeks, range 19–143 weeks.